Homeopathy and Chronic Disease Management: A Critical Review of Evidence, Patient Perspectives and Integrative Healthcare

Abstract

Chronic diseases constitute one of the major challenges facing contemporary healthcare systems because they frequently require long-term management, continuous monitoring, behavioral modification, and sustained patient engagement. Alongside conventional medical treatment, many individuals seek complementary approaches such as homeopathy, particularly when symptoms persist despite conventional therapy or when patients prefer individualized and holistic models of care. Homeopathy is based primarily on the principles of “similia similibus curentur,” or “like cures like,” and potentization through serial dilution and succussion. Its application to chronic disease management remains controversial because the proposed mechanisms of action are not consistent with established pharmacological principles, especially at high dilutions. Nevertheless, homeopathic practice continues to be used for conditions involving respiratory, dermatological, musculoskeletal, gastrointestinal, and psychological symptoms. This research paper critically examines the role of homeopathy in chronic disease management, with particular attention to clinical evidence, patient expectations, quality of life, therapeutic relationships, safety, and the challenges of integrating homeopathy into evidence-based healthcare. Available systematic reviews provide inconsistent conclusions. Some studies report outcomes favorable to homeopathy, whereas other assessments conclude that the evidence is insufficient to demonstrate effectiveness for specific chronic diseases. The paper argues that patients' experiences and preferences should be acknowledged without confusing them with evidence of specific therapeutic efficacy. Homeopathy may be studied as part of broader patient-centered and integrative healthcare models, but claims concerning disease treatment should remain proportional to the quality of available evidence. Future research should emphasize rigorous randomized controlled trials, transparent reporting, long-term outcomes, comparative effectiveness, and assessment of potential harms associated with delayed conventional treatment.